Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease. Clinics, [S. l.], v. 74, p. e824, 2019. DOI: 10.6061/clinics/2019/e824. Disponível em: https://revistas.usp.br/clinics/article/view/157947.. Acesso em: 27 apr. 2024.